This page is part of the HL7 Terminology (v1.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions
Summary
Defining URL: | http://terminology.hl7.org/ValueSet/v3-AdministrationDetectedIssueCode |
Version: | 2.0.0 |
Name: | AdministrationDetectedIssueCode |
Status: | Active |
Title: | AdministrationDetectedIssueCode |
Definition: | Administration of the proposed therapy may be inappropriate or contraindicated as proposed |
OID: | 2.16.840.1.113883.1.11.16657 (for OID based terminology systems) |
Source Resource: | XML / JSON / Turtle |
References
This value set includes codes based on the following rules:
http://terminology.hl7.org/CodeSystem/v3-ActCode
where concept is-a _AdministrationDetectedIssueCodehttp://terminology.hl7.org/CodeSystem/v3-ActCode
Code | Display | |
_AdministrationDetectedIssueCode | AdministrationDetectedIssueCode | Administration of the proposed therapy may be inappropriate or contraindicated as proposed |
This value set contains 61 concepts
Expansion based on:
All codes from system http://terminology.hl7.org/CodeSystem/v3-ActCode
Code | Display | Definition |
_AppropriatenessDetectedIssueCode | AppropriatenessDetectedIssueCode | |
_InteractionDetectedIssueCode | InteractionDetectedIssueCode | |
FOOD | Food Interaction Alert | Proposed therapy may interact with certain foods |
TPROD | Therapeutic Product Alert | Proposed therapy may interact with an existing or recent therapeutic product |
DRG | Drug Interaction Alert | Proposed therapy may interact with an existing or recent drug therapy |
NHP | Natural Health Product Alert | Proposed therapy may interact with existing or recent natural health product therapy |
NONRX | Non-Prescription Interaction Alert | Proposed therapy may interact with a non-prescription drug (e.g. alcohol, tobacco, Aspirin) |
OBSA | Observation Alert | Proposed therapy may be inappropriate or contraindicated due to conditions or characteristics of the patient |
AGE | Age Alert | Proposed therapy may be inappropriate or contraindicated due to patient age |
ADALRT | adult alert | Proposed therapy is outside of the standard practice for an adult patient. |
DOSEHINDA | High Dose for Age Alert | Proposed dosage exceeds standard practice for the patient's age |
DOSELINDA | Low Dose for Age Alert | Proposed dosage is below suggested therapeutic levels for the patient's age |
GEALRT | geriatric alert | Proposed therapy is outside of standard practice for a geriatric patient. |
PEALRT | pediatric alert | Proposed therapy is outside of the standard practice for a pediatric patient. |
COND | Condition Alert | Proposed therapy may be inappropriate or contraindicated due to an existing/recent patient condition or diagnosis |
HGHT | ||
LACT | Lactation Alert | Proposed therapy may be inappropriate or contraindicated when breast-feeding |
PREG | Pregnancy Alert | Proposed therapy may be inappropriate or contraindicated during pregnancy |
WGHT | ||
CREACT | common reaction alert | **Description:**Proposed therapy may be inappropriate or contraindicated because of a common but non-patient specific reaction to the product. **Example:**There is no record of a specific sensitivity for the patient, but the presence of the sensitivity is common and therefore caution is warranted. |
GEN | Genetic Alert | Proposed therapy may be inappropriate or contraindicated due to patient genetic indicators. |
GEND | Gender Alert | Proposed therapy may be inappropriate or contraindicated due to patient gender. |
LAB | Lab Alert | Proposed therapy may be inappropriate or contraindicated due to recent lab test results |
REACT | Reaction Alert | Proposed therapy may be inappropriate or contraindicated based on the potential for a patient reaction to the proposed product |
ALGY | Allergy Alert | Proposed therapy may be inappropriate or contraindicated because of a recorded patient allergy to the proposed product. (Allergies are immune based reactions.) |
INT | Intolerance Alert | Proposed therapy may be inappropriate or contraindicated because of a recorded patient intolerance to the proposed product. (Intolerances are non-immune based sensitivities.) |
RREACT | Related Reaction Alert | Proposed therapy may be inappropriate or contraindicated because of a potential patient reaction to a cross-sensitivity related product. |
RALG | Related Allergy Alert | Proposed therapy may be inappropriate or contraindicated because of a recorded patient allergy to a cross-sensitivity related product. (Allergies are immune based reactions.) |
RAR | Related Prior Reaction Alert | Proposed therapy may be inappropriate or contraindicated because of a recorded prior adverse reaction to a cross-sensitivity related product. |
RINT | Related Intolerance Alert | Proposed therapy may be inappropriate or contraindicated because of a recorded patient intolerance to a cross-sensitivity related product. (Intolerances are non-immune based sensitivities.) |
PREVINEF | previously ineffective | **Definition:**The same or similar treatment has previously been attempted with the patient without achieving a positive effect. |
COMPLY | Compliance Alert | There may be an issue with the patient complying with the intentions of the proposed therapy |
DUPTHPY | Duplicate Therapy Alert | The proposed therapy appears to duplicate an existing therapy |
DUPTHPCLS | duplicate therapeutic alass alert | **Description:**The proposed therapy appears to have the same intended therapeutic benefit as an existing therapy, though the specific mechanisms of action vary. |
DUPTHPGEN | duplicate generic alert | **Description:**The proposed therapy appears to have the same intended therapeutic benefit as an existing therapy and uses the same mechanisms of action as the existing therapy. |
ABUSE | commonly abused/misused alert | **Description:**The proposed therapy is frequently misused or abused and therefore should be used with caution and/or monitoring. |
FRAUD | potential fraud | **Description:**The request is suspected to have a fraudulent basis. |
PLYDOC | Poly-orderer Alert | A similar or identical therapy was recently ordered by a different practitioner. |
PLYPHRM | Poly-supplier Alert | This patient was recently supplied a similar or identical therapy from a different pharmacy or supplier. |
DACT | drug action detected issue | **Description:**Proposed therapy may be contraindicated or ineffective based on an existing or recent drug therapy. |
DOSE | Dosage problem | Proposed dosage instructions for therapy differ from standard practice. |
DOSECOND | dosage-condition alert | **Description:**Proposed dosage is inappropriate due to patient's medical condition. |
DOSEDUR | Dose-Duration Alert | Proposed length of therapy differs from standard practice. |
DOSEDURH | Dose-Duration High Alert | Proposed length of therapy is longer than standard practice |
DOSEDURHIND | Dose-Duration High for Indication Alert | Proposed length of therapy is longer than standard practice for the identified indication or diagnosis |
DOSEDURL | Dose-Duration Low Alert | Proposed length of therapy is shorter than that necessary for therapeutic effect |
DOSEDURLIND | Dose-Duration Low for Indication Alert | Proposed length of therapy is shorter than standard practice for the identified indication or diagnosis |
DOSEH | High Dose Alert | Proposed dosage exceeds standard practice |
DOSEHIND | High Dose for Indication Alert | |
DOSEHINDSA | High Dose for Height/Surface Area Alert | Proposed dosage exceeds standard practice for the patient's height or body surface area |
DOSEHINDW | High Dose for Weight Alert | Proposed dosage exceeds standard practice for the patient's weight |
DOSEIVL | Dose-Interval Alert | Proposed dosage interval/timing differs from standard practice |
DOSEIVLIND | Dose-Interval for Indication Alert | Proposed dosage interval/timing differs from standard practice for the identified indication or diagnosis |
DOSEL | Low Dose Alert | Proposed dosage is below suggested therapeutic levels |
DOSELIND | Low Dose for Indication Alert | |
DOSELINDSA | Low Dose for Height/Surface Area Alert | Proposed dosage is below suggested therapeutic levels for the patient's height or body surface area |
DOSELINDW | Low Dose for Weight Alert | Proposed dosage is below suggested therapeutic levels for the patient's weight |
MDOSE | maximum dosage reached | **Description:**The maximum quantity of this drug allowed to be administered within a particular time-range (month, year, lifetime) has been reached or exceeded. |
TIME | timing detected issue | **Description:**Proposed therapy may be inappropriate or ineffective based on the proposed start or end time. |
ALRTENDLATE | end too late alert | **Definition:**Proposed therapy may be inappropriate or ineffective because the end of administration is too close to another planned therapy. |
ALRTSTRTLATE | start too late alert | **Definition:**Proposed therapy may be inappropriate or ineffective because the start of administration is too late after the onset of the condition. |
_DrugActionDetectedIssueCode | DrugActionDetectedIssueCode | Proposed therapy may be contraindicated or ineffective based on an existing or recent drug therapy |
_TimingDetectedIssueCode | TimingDetectedIssueCode | Proposed therapy may be inappropriate or ineffective based on the proposed start or end time. |
ENDLATE | End Too Late Alert | Proposed therapy may be inappropriate or ineffective because the end of administration is too close to another planned therapy |
STRTLATE | Start Too Late Alert | Proposed therapy may be inappropriate or ineffective because the start of administration is too late after the onset of the condition |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |
History
Date | Action | Custodian | Author | Comment |
2020-05-06 | revise | Vocabulary WG | Ted Klein | Migrated to the UTG maintenance environment and publishing tooling. |
2014-03-26 | revise | 2014T1_2014-03-26_001283 (RIM release ID) | Vocabulary (Woody Beeler) (no record of original request) | Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26 |